BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 16433801)

  • 1. Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery.
    Stenquist B; Ericson MB; Strandeberg C; Mölne L; Rosén A; Larkö O; Wennberg AM
    Br J Dermatol; 2006 Feb; 154(2):305-9. PubMed ID: 16433801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
    Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
    Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery.
    El Hoshy K; Bosseila M; El Sharkawy D; Sobhi R
    Photodiagnosis Photodyn Ther; 2016 Jun; 14():4-8. PubMed ID: 26790611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescence imaging for the demarcation of basal cell carcinoma tumor borders.
    Alkalay R; Alcalay J; Maly A; Ingber A; Fritsch C; Ruzicka T; Enk CD
    J Drugs Dermatol; 2008 Nov; 7(11):1033-7. PubMed ID: 19110733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data.
    Lawrence CM; Haniffa M; Dahl MG
    Br J Dermatol; 2009 Mar; 160(3):573-80. PubMed ID: 19210500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinoma--new aspects of diagnosis and treatment.
    Wennberg AM
    Acta Derm Venereol Suppl (Stockh); 2000; 209():5-25. PubMed ID: 10884941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mohs' method of micrographic surgery as treatment for recurrent basal cell carcinoma].
    van Baardwijk AA; Verhaegh ME; Krekels GA; Vermeulen AH; Neumann HA
    Ned Tijdschr Geneeskd; 1997 Mar; 141(11):524-9. PubMed ID: 9190509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma.
    Paoli J; Daryoni S; Wennberg AM; Mölne L; Gillstedt M; Miocic M; Stenquist B
    Acta Derm Venereol; 2011 Oct; 91(6):689-93. PubMed ID: 21681360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative assessment of basal cell carcinoma using conventional fluorescence diagnosis.
    Neus S; Gambichler T; Bechara FG; Wöhl S; Lehmann P
    Arch Dermatol Res; 2009 Apr; 301(4):289-94. PubMed ID: 18979108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of fluorescence diagnosis of basal cell carcinoma using a digital flash light-based imaging system.
    Gambichler T; Moussa G; Altmeyer P
    Photodermatol Photoimmunol Photomed; 2008 Apr; 24(2):67-71. PubMed ID: 18353085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year results of curettage-cryosurgery of selected large primary basal cell carcinomas on the nose: an alternative treatment in a geographical area underserved by Mohs' surgery.
    Nordin P; Larkö O; Stenquist B
    Br J Dermatol; 1997 Feb; 136(2):180-3. PubMed ID: 9068728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery.
    Redondo P; Marquina M; Pretel M; Aguado L; Iglesias ME
    Arch Dermatol; 2008 Jan; 144(1):115-7. PubMed ID: 18209183
    [No Abstract]   [Full Text] [Related]  

  • 13. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
    Cohen PR; Schulze KE; Nelson BR
    Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
    Florell SR; Layfield LJ; Gerwels JW
    J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face.
    Essers BA; Dirksen CD; Nieman FH; Smeets NW; Krekels GA; Prins MH; Neumann HA
    Arch Dermatol; 2006 Feb; 142(2):187-94. PubMed ID: 16490846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of Mohs' micrographic surgery in two English centres.
    Julian CG; Bowers PW
    Br J Dermatol; 1997 Apr; 136(4):515-8. PubMed ID: 9155950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous lip tumours treated with Mohs micrographic surgery: clinical features and surgical outcome.
    Leibovitch I; Huilgol SC; Selva D; Paver R; Richards S
    Br J Dermatol; 2005 Dec; 153(6):1147-52. PubMed ID: 16307650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
    Holmkvist KA; Rogers GS; Dahl PR
    J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of photodynamic diagnosis in defining the lateral border between a tumor and a tumor-free area during Mohs micrographic surgery.
    Lee CY; Kim KH; Kim YH
    Dermatol Surg; 2010 Nov; 36(11):1704-10. PubMed ID: 20840493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of photodynamic diagnosis-guided Mohs micrographic surgery in primary squamous cell carcinoma.
    Jeon SY; Kim KH; Song KH
    Dermatol Surg; 2013 Dec; 39(12):1774-83. PubMed ID: 24299572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.